Ask AI

Lymphomas

Share

Program Content

Activities

  • PulseCast Lymphomas ASH 2025
    PulseCast: Highlights in Lymphomas From the 2025 ASH Annual Meeting
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 19, 2025

Activities

CLL17
CLL17: Phase III Trial of Continuous Ibrutinib vs Fixed-Duration Venetoclax Plus Obinutuzumab or Venetoclax Plus Ibrutinib for Untreated CLL
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 10, 2025

CaDAnCe 101
CaDAnCe-101 Update: Phase I Study Evaluating BTK Degrader BGB-16673 in R/R CLL/SLL
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 11, 2025

Sonrotoclax RR MCL
Phase I/II Trial of Sonrotoclax (BGB-11417) in R/R Mantle Cell Lymphoma After Prior BTK Inhibitor Therapy 
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 11, 2025

BRUIN CLL 314
BRUIN CLL-314: Pirtobrutinib vs Ibrutinib in Treatment-Naive and BTKi-Naive R/R CLL/SLL
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 12, 2025

Surovatamig RR FL
Phase I Trial of CD19 x CD3 T-Cell Engager Surovatamig (AZD0486) in R/R Follicular Lymphoma: 3-Yr Follow-up
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 12, 2025

BRUIN CLL 313
BRUIN CLL-313: Pirtobrutinib vs Bendamustine + Rituximab in Treatment-Naive CLL/SLL
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 12, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education in partnership with Smart Patients.

Supporters

Supported by educational grants from AstraZeneca, BeOne Medicines, Genentech, Geron Corporation, Incyte, Johnson & Johnson, Lilly, and Novartis Pharmaceuticals Corporation.

AstraZeneca

BeOne Medicines

Genentech

Geron Corporation

Incyte

Johnson & Johnson

Lilly

Novartis Pharmaceuticals Corporation

Partners

Smart Patients

ProCE Banner